CLN
CELON PHARMA
GPW
LISTED
Shareholders
as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5%
FREE FLOAT
The portion of capital not covered by notifications above 5% — its composition is not publicly known.
29.06%
15,663,384 shares
LARGEST STAKE
55.7%
Glatton Sp.z o.o.
TOP 3 CONCENTRATION
Combined stake of the three largest shareholders above the 5% threshold.
70.94%
3 entities above 5%
LATEST CHANGE
June 24, 2026
ESPI (wykaz z WZ)
Ownership structure
stakes per latest notifications · share count normalized to 53,911,500 shares outstanding
SHAREHOLDERS ≥5% 70.94%
FREE FLOAT 29.06%
HOLDER
STAKE
SHARES
VOTES
NOTIFICATION
Glatton Sp.z o.o.
55.7%
30,027,531
65.34%
September 19, 2026
Tang Capital Management. LLC
7.67%
4,137,000
6%
September 19, 2026
Generali Powszechne Towarzystwo Emerytalne SA
7.57%
4,083,585
5.93%
September 19, 2026
Other
29.06%
15,663,384
22.73%
—
Glatton Sp.z o.o.
55.7%
30,027,531 shares · notification September 19, 2026
Tang Capital Management. LLC
7.67%
4,137,000 shares · notification September 19, 2026
Generali Powszechne Towarzystwo Emerytalne SA
7.57%
4,083,585 shares · notification September 19, 2026
Other
29.06%
15,663,384 shares · composition undisclosed
Notification history
crossings above/below the 5% / 10% / 20% thresholdsJune 24, 2026
ESPI (wykaz z WZ) — baseline reading
Glatton sp. z o.o.:
new in the registry, 65.39%
→
Capital and votes
Number of shares
53,911,500
ISIN
PLCLNPH00015
Sector
Produkcja Leków
Market
GPW
Country
PL
Listing date
December 01, 2016
Where this data comes from
The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.
Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.
Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.